KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $263,572 | -37.3% | 18,962 | +3.7% | 0.00% | -33.3% |
Q2 2023 | $420,441 | -22.2% | 18,288 | +0.2% | 0.00% | -25.0% |
Q1 2023 | $540,718 | +21.1% | 18,249 | +2.0% | 0.00% | +33.3% |
Q4 2022 | $446,435 | +14.2% | 17,886 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $391,000 | +12.4% | 17,951 | +1.4% | 0.00% | +50.0% |
Q2 2022 | $348,000 | -51.8% | 17,698 | +3.7% | 0.00% | -50.0% |
Q1 2022 | $722,000 | -37.7% | 17,060 | -6.6% | 0.00% | -33.3% |
Q4 2021 | $1,159,000 | +4.9% | 18,261 | -2.9% | 0.01% | 0.0% |
Q3 2021 | $1,105,000 | +40.6% | 18,807 | +16.1% | 0.01% | +100.0% |
Q2 2021 | $786,000 | +244.7% | 16,198 | +175.6% | 0.00% | +200.0% |
Q1 2021 | $228,000 | -37.2% | 5,877 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $363,000 | – | 5,861 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
AtonRa Partners | 19,172 | $266,491 | 0.56% |
Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |